SCHEMBL4083067

SCHEMBL4083067

O=C(c1ccc(Cl)cc1)c1ccccc1NC(=O)C(Cl)(Cl)Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.53
ALDH1A1 P00352 5/20 0.50
BDKRB1 P46663 1/20 0.49
MAPT P10636 4/20 0.47
LMNA P02545 2/20 0.47
PDK1 Q15118 1/20 0.46
PDK2 Q15119 1/20 0.46
PDK3 Q15120 1/20 0.46
PDK4 Q16654 1/20 0.46
CYP2C9 P11712 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C19 P33261 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 3/20 0.45
TP53 P04637 3/20 0.45
RAB9A P51151 3/20 0.45
KMT2A Q03164 3/20 0.45
NPC1 O15118 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8569129 0.89 ALDH1A1 (0.62) ALDH1A1BDKRB1MAPTLMNAPDK1
SCHEMBL8569299 0.82 MAPT (0.67) ALDH1A1MAPTLMNACYP2C9CYP1A2
SCHEMBL6357109 0.81 PDK1 (0.72) PDK1PDK2PDK3PDK4
SCHEMBL16109601 0.77 RXFP1 (0.48) NR4A1ALDH1A1BDKRB1MAPTLMNA
SCHEMBL3444656 0.76 NR4A1 (0.84) NR4A1ALDH1A1MAPTCYP2C9NPSR1
SCHEMBL6510419 0.76 PDK1 (0.62) ALDH1A1MAPTLMNAPDK1PDK2
SCHEMBL29380114 0.75 ALDH1A1 (0.61) NR4A1ALDH1A1MAPTLMNAL3MBTL1
SCHEMBL10413044 0.75 RAB9A (0.67) ALDH1A1MAPTLMNANPSR1L3MBTL1
SCHEMBL6169653 0.74 MEN1 (0.56) ALDH1A1LMNACYP1A2CYP2C19MEN1
SCHEMBL29118239 0.73 ALDH1A1 (0.58) ALDH1A1BDKRB1MAPTPDK1PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090062317-A1 MEDICINAL USE OF RECEPTOR LIGANDS 7TM PHARMA A/S (DK) 2009-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062317-A1 MEDICINAL USE OF RECEPTOR LIGANDS MCHR1, MCHR2, MC1R NR4A1 267/4885ALDH1A1 1058/4885BDKRB1 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.